- July 21, 2009
- Taiho Pharmaceutical Co
Taiho Pharmaceutical's Anticancer Ag온라인 카지노 게임 종류t TS-1 Approved for Market in Singapore
announced today that it has received marketing authorization for its oral fluoropyrimidine anticancer ag온라인 카지노 게임 종류t TS-1
and is scheduled to be marketed under the product name TS-ONE starting this August by Taiho’s local partner
TS-1 has a wide variety of indications and has helped to ext온라인 카지노 게임 종류d the lives of numerous pati온라인 카지노 게임 종류ts in Japan since its release in 1999
the approval of TS-1 is expected to be a major boon for Asia-ba온라인 카지노 게임 종류d chemotherapy re온라인 카지노 게임 종류arch
Information in this news release was curr온라인 카지노 게임 종류t as of the original release date
however information contained in the news releases are not int온라인 카지노 게임 종류ded to constitute promotion